Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KALEIDO BIOSCIENCES, INC.

(KLDO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about KALEIDO BIOSCIENCES, INC.
01/21Kaleido Reports Findings From Study Data of Proposed Inflammatory Bowel Disease Treatme..
MT
01/21Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 ..
GL
01/21Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 ..
GL
2021KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) dropped from NASDAQ Biotechnology Index
CI
2021Kaleido Biosciences Expands and Extends Collaboration With Janssen
MT
2021Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potent..
GL
2021Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potent..
CI
2021Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ..
GL
2021Chardan Adjusts Price Target on Kaleido Biosciences to $11 From $15 on Pipeline Assets ..
MT
2021Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer
GL
2021Kaleido Biosciences, Inc. to Appoint Alison Long as Chief Medical Officer, Effective De..
CI
2021JMP Securities Adjusts Price Target on Kaleido Biosciences to $22 From $25, Maintains M..
MT
2021KALEIDO BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition ..
AQ
2021Press Release issued by Kaleido Biosciences, Inc., dated November 1, 2021, furnished he..
PU
2021Kaleido Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Month..
CI
2021Kaleido Biosciences Reports Third Quarter 2021 Financial Results
AQ
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021KALEIDO BIOSCIENCES : Morgan Stanley Downgrades Kaleido Biosciences to Underweight from Eq..
MT
2021KALEIDO BIOSCIENCES : to Participate in the Jefferies Virtual Next Generation IBD Therapeu..
AQ
2021KALEIDO BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021KALEIDO BIOSCIENCES : Says Bowel Disease Drug Trial Meets Primary Safety Endpoint
MT
2021KALEIDO BIOSCIENCES : Announces New Clinical and Preclinical Data Supporting Advancement o..
AQ
2021Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement ..
CI
2021Kaleido Biosciences to Host Virtual R&D Presentation to Discuss Clinical Data and Pipel..
GL
2021Kaleido Biosciences, Inc. to Host Virtual R&D Presentation to Discuss Clinical Data and..
CI
2021KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to S&P Global BMI Index
CI
2021KALEIDO BIOSCIENCES, INC. : Other Events (form 8-K)
AQ
2021Kaleido Biosciences, Inc. Receives Warning Letter from the U.S. Food and Drug Administr..
CI
2021Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Hea..
GL
2021KALEIDO BIOSCIENCES : Press Release issued by Kaleido Biosciences, Inc., dated August 11, ..
PU
2021KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2021Kaleido Biosciences Reports Second Quarter 2021 Financial Results
GL
2021Kaleido Biosciences, Inc. Announces Unaudited Consolidated Earnings Results for the Sec..
CI
2021KALEIDO BIOSCIENCES : Teams Up With COPD Foundation to Advance KB109 into Phase 2a Clinica..
MT
2021KALEIDO BIOSCIENCES : and the COPD Foundation Announce a Strategic Collaboration to Advanc..
AQ
2021Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advan..
CI
2021KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statement..
AQ
2021KALEIDO BIOSCIENCES : Announces New Chairperson Appointment to its Board of Directors
AQ
2021Kaleido Biosciences, Inc. Announces Appointment of Theo Melas-Kyriazi as Chairperson of..
CI
2021KALEIDO BIOSCIENCES : to Participate in the 41st Annual Canaccord Genuity Growth Conferenc..
AQ
2021KALEIDO BIOSCIENCES : Appoints Jerald Korn Chief Operating Officer
MT
2021KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Kaleido Biosciences, Inc. Appoints Jerald Korn as Chief Operating Officer
CI
2021KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 3000E Value Index
CI
2021KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell Small Cap Comp Value Index
CI
2021KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell Microcap Value Index
CI
2021KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 3000 Value Index
CI
2021KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 2500 Value Index
CI
2021KALEIDO BIOSCIENCES, INC.(NASDAQGS : KLDO) added to Russell 2000 Value Index
CI
2021KALEIDO BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Other Eve..
AQ
2021Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference
GL
2021Certain Stock Options of Kaleido Biosciences, Inc. are subject to a Lock-Up Agreement E..
CI
2021Certain Restricted Stock Units of Kaleido Biosciences, Inc. are subject to a Lock-Up Ag..
CI
2021Certain Common Stock of Kaleido Biosciences, Inc. are subject to a Lock-Up Agreement En..
CI
2021KALEIDO BIOSCIENCES' : Q1 Loss Narrows; Expects Enough Funds to Operate Into Q1 2022
MT
2021KALEIDO BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2021Kaleido Biosciences Reports First Quarter 2021 Financial Results
GL
2021Kaleido Biosciences, Inc. and Cadena Bio, Inc. Enter into Third Amendment to Loan and S..
CI
2021Kaleido Biosciences, Inc. Announces Unaudited Consolidated Earnings Results for the Fir..
CI
2021KALEIDO BIOSCIENCES : Announces Collaboration with Robert Jenq, M.D., to Explore Potential..
AQ
2021KALEIDO BIOSCIENCES : to Collaborate with MD Anderson Cancer Center Expert on Microbiome T..
MT
2021Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potentia..
GL
2021Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potentia..
CI
2021Kaleido Biosciences to Participate in Jefferies Microbiome-Based Therapeutics Summit
GL
2021KALEIDO BIOSCIENCES : Reports Positive Results from Non-IND Study
AQ
2021SECTOR UPDATE : Health Care Stocks Climb Premarket Wednesday
MT
2021KALEIDO BIOSCIENCES : Reports Positive Results From KB109 Study to Treat COVID-19; Shares ..
MT
2021KALEIDO BIOSCIENCES, INC. : Regulation FD Disclosure, Other Events, Financial Statements a..
AQ
2021Kaleido Biosciences Reports Positive Results from Non-IND Study Demonstrating a Reducti..
GL
2021Kaleido Biosciences, Inc. Reports Positive Results from Non-IND Study Demonstrating a R..
CI
2021AGILENT TECHNOLOGIES : Brings in Former Kaleido Biosciences Exec as Chief Medical Officer
MT
2021KALEIDO BIOSCIENCES : Share Dilution Drives Price Target Cut at Chardan
MT
2021KALEIDO BIOSCIENCES : Chardan Adjusts Price Target on Kaleido Biosciences to $15 From $17...
MT
2021KALEIDO BIOSCIENCES : Posts Narrower Q4 Loss
MT
2021Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
GL
1  2  3  4Next
Upcoming event on KALEIDO BIOSCIENCES, INC.
03/07/22